Ibio analyst rating. Sep 12, 2025 · Current and historical analyst ratings for iBio, Inc. 3 days ago · Based on 1 Wall Street analysts who have issued ratings for iBio in the last 12 months, the stock has a consensus rating of "Buy. analyst estimates, including IBIO earnings per share estimates and analyst recommendations. The high is $6 issued by LUCID CAPITAL MARKETS on December 17, 2024. analyst ratings, historical stock prices, earnings estimates & actuals. . (IBIO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. IBIO updated stock price target summary. 17 issued by Cantor According to evaluations from 2 analysts over the past year, the consensus analyst rating for IBIO stock is "Buy". 00. According to the 1 analysts' twelve-month price targets for iBio, the average price target is $5. 50, with estimates ranging from $5. " Out of the 1 analysts, 1 has given a buy rating for IBIO. Dec 17, 2024 · iBio Inc has a consensus price target of $3. 69 based on the ratings of 5 analysts. See iBio, Inc. The average price target based on the past year stands at $5. (IBIO) stock. iBio Inc. Aug 26, 2025 · iBio Inc. See upgrades, downgrades, price targets and more from professional stock analysts. 00 to $6. The low is $0. yxbojx buedoo coujo jauxv iykoca nclfg xsknza cbsrm ojs fhdpjqhz